Rosacea: Dermatologist Dr Sandra Lee Explains How You Can Minimize Symptoms
There are things those living with rosacea can do do minimize symptoms.
Category: Eczema
Eczema
PopularEczema
Latest
The National Eczema Association and Pediatric Dermatology Research Alliance Receive Collaborative Engagement Award from PCORI
Award will support education in patient-centered outcomes research and emerging pediatric eczema therapies.
All
Latest
First U.S. Women Receive Breast Augmentation with FDA-Approved Motiva Implants
Establishment Labs Holdings Inc, a global medical technology company specializing in women’s health, announces the first U.S. breast augmentations using Motiva Implants.
Presentation Suggests Racial Disparities Among Kids with Eczema
A presentation at this year’s virtual American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting reveals the disparities that exist for Black and Hispanic children when it comes to Atopic Dermatitis (AD), commonly known as eczema.
Read More
Vitamin D Lessens Symptoms of Severe Eczema in Children
Vitamin D supplementation eased the symptoms experienced by children with severe atopic dermatitis, or eczema, in a recent randomized controlled trial published in Pharmacology Research & Perspectives.
Read More
Patient Experiences and Concerns With Eczema
Patients with eczema and their carers experience frustration managing a disease often seen as mundane but has significant psychosocial impact, according to Dermatology Advisor.
Read More
Researcher IDs Gene Biomarker That Differentiates Between Atopic Dermatitis and Psoriasis
Researchers may be able to provide a non-invasive alternative to skin biopsy to correctly distinguish between two highly inflammatory diseases, they suggest in a media release.
Read More
FDA Approves Wynzora Cream for Adults with Plaque Psoriasis
The US Food and Drug Administration (FDA) has approved Wynzora Cream (calcipotriene and betamethasone dipropionate, w/w 0.005%/0.064%) for once-daily topical treatment of plaque psoriasis in adults 18 years of age or older, MC2 Therapeutics announces.
Read More
Minimal Link Between Eczema and Most Cancers
Atopic eczema wasn’t tied to a significantly increased risk for most cancers, according to research from England and Denmark, MedPage Today reports.
Read More
Researchers Uncover Novel Approach for Treating Eczema
Researchers at the University of British Columbia (UBC) and Vancouver Coastal Health Research Institute (VCHRI) have identified a key enzyme that contributes to eczema, which may lead to better treatment to prevent the skin disorder’s debilitating effects.
Read More
First-Ever Guidelines for Pediatric Psoriasis Bring Unique Concerns to Forefront
Although three biologic agents are now approved for use in some children, experts hope the guidelines will prompt further research so children and their families will someday have an array of treatment options available, as adults with psoriasis do today, they note in Healio.
Read More
Psoriasis Patients’ Mental Health Is More Than Skin-Deep, Per Study
Skin symptoms have an important impact on mental health, but other somatic diseases associated with psoriasis can cause even more harm to mental health, researchers suggest in JAMA Dermatology.
Read More
Researchers Identify Mechanisms That Make Skin a Protective Barrier
A Mount Sinai research team has identified one of the mechanisms that establish the skin as a protective barrier, a breakthrough that is critical to understanding and treating common skin conditions including eczema and psoriasis, according to a study published recently in Genes & Development.
Read More
Examining the Safety of Pediatric Psoriasis Treatment
Psoriasis has many treatment options, and an increasing number of cases are being treated with systemic medication. The safety of such medications is not well known, but a new study provides some safety data, Contemporary Pediatrics reports.
Read More
Hoth Therapeutics Procures Full Licensing Rights for the BioLexa Platform for Treating Atopic Dermatitis
Hoth Therapeutics Inc announces that it has obtained exclusive worldwide licensing rights to the BioLexa Platform, a proprietary, patented antimicrobial therapy focused on treating atopic dermatitis.
Read More
RAPT Therapeutics Highlights Early Results for RPT193 at Society for Investigative Dermatology Meeting
Encouraging results from preclinical and healthy volunteer studies for RPT193 were presented at the Society for Investigative Dermatology (SID) Meeting. RPT193 is an oral therapy in development for the treatment of atopic dermatitis and other allergic inflammatory diseases, BioSpace reports.
Read More
Addressing Skin Pain in Atopic Dermatitis
Results of emerging research highlight the association of skin pain with atopic dermatitis, including recent studies reporting skin pain in 43% to 78% of patients with eczema, according to Dermatology Advisor.
Read More
Are Patients With Psoriasis at Increased Risk for Serious Infection, Hospitalization?
Psoriasis is associated with increased risk for serious infection, according to the results of cohort study data published in the British Journal of Dermatology.
Read More